Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review

Dominic L Palazzolo, Dominic L Palazzolo

Abstract

Electronic cigarette (e-cigarette) use, or vaping, in the United States and worldwide is increasing. Their use is highly controversial from scientific, political, financial, psychological, and sociological ideologies. Given the controversial nature of e-cigarettes and vaping, how should medical care providers advise their patients? To effectively face this new challenge, health care professionals need to become more familiar with the existing literature concerning e-cigarettes and vaping, especially the scientific literature. Thus, the aim of this article is to present a review of the scientific evidence-based primary literature concerning electronic cigarettes and vaping. A search of the most current literature using the pubmed database dating back to 2008, and using electronic cigarette(s) or e-cigarette(s) as key words, yielded a total of 66 highly relevant articles. These articles primarily deal with (1) consumer-based surveys regarding personal views on vaping, (2) chemical analysis of e-cigarette cartridges, solutions, and mist, (3) nicotine content, delivery, and pharmacokinetics, and (4) clinical and physiological studies investigating the effects of acute vaping. When compared to the effects of smoking, the scant available literature suggests that vaping could be a "harm reduction" alternative to smoking and a possible means for smoking cessation, at least to the same degree as other Food and Drug Administration-approved nicotine replacement therapies. However, it is unclear if vaping e-cigarettes will reduce or increase nicotine addiction. It is obvious that more rigorous investigations of the acute and long-term health effects of vaping are required to establish the safety and efficacy of these devices; especially parallel experiments comparing the cardiopulmonary effects of vaping to smoking. Only then will the medical community be able to adequately meet the new challenge e-cigarettes and vaping present to clinical medicine and public health.

Keywords: electronic cigarettes; harm reduction; nicotine addiction; nicotine replacement; smoking cessation; vaping.

References

    1. Modi N, Schmid B, Miller R. Clearing the Smoke on e-Cigarettes. New York, NY: UBS Securities LLC; (2012). Available from:
    1. Woodcock J. Letter to Mr. Matt Salmon, President, Electronic Cigarette Association. (2013). Available from:
    1. Electronic Cigarette Consumer Reviews (ECCR) ECCR. (2013). Available from:
    1. Westenberger BJ. Evaluation of e-Cigarettes. St. Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis; (2009). Available from:
    1. Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 Federal Food, Drug and Cosmetic Act as Amended through 2013, Pub L No 113-5, 127 Stat 161 (2013). Available from:
    1. Smoking Everywhere, Inc. v. U.S. Food and Drug Administration and U.S. Department of Health and Human Services, 1:09-cv-00771-RJL (D DC 2009). Available from:
    1. Sottera Inc., Doing Business as NJOY v. Food and Drug Administration et al. (DC Cir 2010) Available from:
    1. U.S. FDA Electronic cigarettes (e-cigarettes). News Events. (2013). Available from:
    1. Laugesen M. Safety Report on the Ruyan® e-Cigarette and Inhaled Aerosol. Christchurch: Health New Zealand Ltd; (2008). Available from:
    1. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy (2011) 32:16–3110.1057/jphp.2010.41
    1. McAuley TR, Hopke PK, Zhao J, Babaian S. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol (2012) 24:850–710.3109/08958378.2012.724728
    1. Foulds J, Veldheer S, Berg A. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract (2011) 65:1037–4210.1111/j.1742-1241.2011.02751.x
    1. Foulds J, Veldheer S. Commentary on Etter & Bullen (2011): could e-cigs become the ultimate nicotine maintenance device? Addiction (2011) 106:2029–3010.1111/j.1360-0443.2011.03532.x
    1. Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act of 2009, Pub L No 111-31, 113 Stat 1776 (2009). Available from:
    1. Council on Science and Public Health (CSAPH), American Medical Association Use of electronic cigarettes in smoking cessation programs. Report 6 (A-10), 159th Annual Meeting Chicago, IL: American Medical Association House of Delegates Available from:
    1. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation (2010) 122:1520–4410.1161/CIR.0b013e3181f432c3
    1. Avdalovic MV, Murin S. Electronic cigarettes: no such thing as a free lunch…Or puff. Chest (2012) 141:1371–210.1378/chest.12-0205
    1. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control (2013) 22:19–2310.1136/tobaccocontrol-2011-050044
    1. Kralikova E, Kubatova S, Truneckova K, Kmetova A, Hajek P. The electronic cigarette: what proportion of smokers have tried it and how many use it regularly? Addiction (2012) 107:1528–910.1111/j.1360-0443.2012.03916.x
    1. Kralikova E, Novak J, West O, Kmetova A, Hajek P. Do e-cigarettes have the potential to compete with conventional cigarettes? A survey of conventional cigarette smokers’ experiences with e-cigarettes. Chest (2013) 144:1609–1410.1378/chest.12-2842
    1. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health (2010) 10:231.10.1186/1471-2458-10-231
    1. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction (2011) 106:2017–2810.1111/j.1360-0443.2011.03505.x
    1. Dawkins L, Turner J, Roberts A, Soar K. ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction (2013) 108:1115–2510.1111/add.12150
    1. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in great britain. Nicotine Tob Res (2013) 15:1737–4410.1093/ntr/ntt057
    1. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse (2013) 7:139–4610.4137/SART.S12756
    1. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract (2013) 8:5.10.1186/1940-0640-8-5
    1. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an Internet survey. Drug Alcohol Rev (2013) 32:133–4010.1111/j.1465-3362.2012.00512.x
    1. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health (2011) 11:786.10.1186/1471-2458-11-786
    1. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med (2013).10.1007/s11739-013-0977-z
    1. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One (2013) 8:e66317.10.1371/journal.pone.0066317
    1. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health (2013) 10:446–6110.3390/ijerph10020446
    1. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res (2013) 15:1787–9110.1093/ntr/ntt061
    1. Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res (2013) 15:e59.10.2196/jmir.2324
    1. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA. Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. Am J Public Health (2013) 103:e57–6210.2105/AJPH.2013.301453
    1. Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M. Electronic cigarette use by college students. Drug Alcohol Depend (2013) 131:214–2110.1016/j.drugalcdep.2013.05.001
    1. Cho JH, Shin E, Moon SS. Electronic-cigarette smoking experience among adolescents. J Adolesc Health (2011) 49:542–610.1016/j.jadohealth.2011.08.001
    1. Pepper JK, Reiter PL, McRee AL, Cameron LD, Gilkey MB, Brewer NT. Adolescent males’ awareness of and willingness to try electronic cigarettes. J Adolesc Health (2013) 52:144–5010.1016/j.jadohealth.2012.09.014
    1. Choi K, Fabian L, Mottey N, Corbett A, Forster J. Young adults’ favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study. Am J Public Health (2012) 102:2088–9310.2105/AJPH.2011.300525
    1. Choi K, Forster J. Characteristics associated with awareness, perceptions, and use of electronic nicotine delivery systems among young US Midwestern adults. Am J Public Health (2013) 103:556–6110.2105/AJPH.2012.300947
    1. Goniewicz ML, Zielinska-Danch W. Electronic cigarette use among teenagers and young adults in Poland. Pediatrics (2012) 130:e879–8510.1542/peds.2011-3448
    1. Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control (2003) 12:21–710.1136/tc.12.1.21
    1. Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, et al. Efficacy of the nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res (2006) 8:555–6410.1080/14622200600789916
    1. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2012) 11:CD000146.10.1002/14651858.CD000146.pub4
    1. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction (2004) 99:29–3810.1111/j.1360-0443.2004.00540.x
    1. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med (2011) 40:472–510.1016/j.amepre.2010.12.006
    1. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet (2013).10.1016/S0140-6736(13)61842-5
    1. Li J, Bullen C, Newcombe R, Walker N, Walton D. The use and acceptability of electronic cigarettes among New Zealand smokers. N Z Med J (2013) 126:48–57
    1. Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med (2011) 365:193–510.1056/NEJMp1105249
    1. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health (2011) 8:613–2810.3390/ijerph8020613
    1. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One (2013) 8:3.10.1371/journal.pone.0057987
    1. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res (2006) 8:309–1310.1080/14622200500490151
    1. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res (2013) 15:158–6610.1093/ntr/nts103
    1. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control (2013).10.1136/tobaccocontrol-2012-050859
    1. Schripp T, Markewitz D, Thornley S, Glover M, Laugesen M. Does e-cigarette consumption cause passive vaping? Indoor Air (2013) 23:25–3110.1111/j.1600-0668.2012.00792.x
    1. Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A (2013) 1291:48–5510.1016/j.chroma.2013.03.035
    1. Pellegrino RM, Tinghino B, Mangiaracina G, Marani A, Vitali M, Protano C, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig (2012) 24:279–88
    1. Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A (2010) 1217:7547–5510.1016/j.chroma.2010.10.018
    1. Moorea TW, Allgirea JF, Woodruffa JT, Ahadia SS, Blacka JC, Westenberger BJ. Analysis of electronic cigarette Cartridges, refill solutions and smoke from nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol (2011) 34:1442–5810.1080/10826076.2011.572213
    1. Bullen C, McRobbie H, Thornley S, Glover M, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control (2010) 19:98–10310.1136/tc.2009.031567
    1. Cheah NP, Chong NW, Tan J, Morsed FA, Yee SK. Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control (2012).10.1136/tobaccocontrol-2012-050483
    1. Flouris AD, Oikonomou DN. Electronic cigarettes: miracle or menace? BMJ (2010) 340:c311.10.1136/bmj.c311
    1. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control (2013).10.1136/tobaccocontrol-2012-050604
    1. Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction (2013) 108:1671–910.1111/add.12235
    1. Chu VL. Nicotine replacement therapy for tobacco use cessation: reference table. J Pharm Pract (2006) 19:297–30010.1177/0897190007300456
    1. Trtchounian A, Talbot P. Electronic nicotine delivery systems: is there a need for regulation? Tob Control (2011) 20:47–5210.1136/tc.2010.037259
    1. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tob Control (2010) 19:87–810.1136/tc.2009.033498
    1. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev (2010) 19:1945–5310.1158/1055-9965.EPI-10-0288
    1. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA (1999) 281:72–610.1001/jama.281.1.72
    1. Anczak JD, Nogler RA., II Tobacco cessation in primary care: maximizing intervention strategies. Clin Med Res (2003) 1:201–1610.3121/cmr.1.3.201
    1. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler – comparison with cigarette smoking. Eur J Clin Pharmacol (2000) 55:737–4110.1007/s002280050007
    1. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis DM. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs (2004) 9:39–5310.1517/14728214.9.1.39
    1. Sahu SK, Tiwari M, Bhangare RC, Pandit GG. Particle size distributions of mainstream and exhaled cigarette smoke and predictive deposition in human respiratory tract. Aerosol Air Qual Res (2013) 13:324–32
    1. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res (2012) 15:501–810.1093/ntr/nts165
    1. Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol (2012) 24:976–8410.3109/08958378.2012.744781
    1. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res (2013) 15:267–7010.1093/ntr/ntr316
    1. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) (2013).10.1007/s00213-013-3249-8
    1. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 107:1493–50010.1111/j.1360-0443.2012.03791.x
    1. Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J (2011) 38:1219–2010.1183/09031936.00066011
    1. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol (2013) 25:91–10110.3109/08958378.2012.758197
    1. Benowitz NL, Hansson A, Jacob P., III Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension (2002) 39:1107–1210.1161/01.HYP.0000018825.76673.EA
    1. Najem B, Houssière A, Pathak A, Janssen C, Lemogoum D, Xhaët O, et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension (2006) 47:1162–710.1161/01.HYP.0000219284.47970.34
    1. Czogala J, Cholewinski M, Kutek A, Zielinska-Danch W. Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers. Przegl Lek (2012) 69:841–5
    1. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res Public Health (2013) 10:2500–1410.3390/ijerph10062500
    1. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res (2010) 12:905–1210.1093/ntr/ntq114
    1. Hua M, Yip H, Talbot P. Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos. J Med Internet Res (2013) 15:e59.10.1136/tobaccocontrol-2011-050226
    1. Williams M, Talbot P. Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res (2011) 13:1276–8310.1093/ntr/ntr164
    1. Sherwood N. Effects of nicotine on human pschomotor performance. Hum Psychopharmacol (1993) 8:155–8410.1002/hup.470080302
    1. Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) (2010) 210:453–6910.1007/s00213-010-1848-1
    1. Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull (1996) 52:58–7310.1093/oxfordjournals.bmb.a011533
    1. Dawkins L, Turner J, Crowe E. Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychopharmacology (Berl) (2013) 227:377–8410.1007/s00213-013-2983-2
    1. Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addict Behav (2012) 37:970–310.1016/j.addbeh.2012.03.004
    1. Evans DE, Drobes DJ. Nicotine self-medication of cognitive-attentional processing. Addict Bio (2009) 14:32–4210.1111/j.1369-1600.2008.00130.x
    1. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci (2004) 5:55–6510.1038/nrn1298
    1. Lewis A, Miller JH, Lea RA. Monoamine oxidase and tobacco dependence. Neurotoxicology (2007) 28:182–9510.1016/j.neuro.2006.05.019
    1. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A (1996) 93:14065–910.1073/pnas.93.24.14065
    1. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature (1996) 379:733–610.1038/379733a0
    1. Casella G, Caponnetto P, Polosa R. Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis (2010) 1:95–10610.1177/2040622310374896
    1. Gross J, Stitzer ML. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology (Berl) (1989) 98:334–4110.1007/BF00451684
    1. McCauley L, Markin C, Hosmer D. An unexpected consequence of electronic cigarette use. Chest (2012) 141:1110–310.1378/chest.11-1334
    1. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest (2012) 141:1400–610.1378/chest.11-2443
    1. Hansson L, Choudry NB, Karlsson JA, Fuller RW. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1994) 76:2420–7
    1. Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr Opin Allergy Clin Immunol (2005) 5:49–5610.1097/00130832-200502000-00010
    1. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 53:91–510.1136/thx.53.2.91
    1. Taylor DR, Pijnenburg MW, Smith AD, de Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax (2006) 61:817–2710.1136/thx.2005.056093
    1. Taylor DR, Mandhane P, Greene JM, Hancox RJ, Filsell S, McLachlan CR, et al. Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir Res (2007) 8:82.10.1186/1465-9921-8-82
    1. Karrasch S, Ernst K, Behr J, Heinrich J, Huber RM, Nowak D, et al. Exhaled nitric oxide and influencing factors in a random population sample. Respir Med (2011) 105:713–810.1016/j.rmed.2010.11.002
    1. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J (2006) 28:339–4510.1183/09031936.06.00113705
    1. Habib SS, Ahmed SM, Al Drees AM, Husain A. Effect of cigarette smoking on fractional exhaled nitric oxide in Saudi medical college students. J Pak Med Assoc (2011) 61:120–3
    1. Yoda Y, Otani N, Hasunuma H, Kanegae H, Shima M. Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research. BMC Pulm Med (2012) 12:68.10.1186/1471-2466-12-68
    1. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest (1997) 112:313–810.1378/chest.112.2.313
    1. McMillan K, Bredt DS, Hirsch DJ, Snyder SH, Clark JE, Masters BS. Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci U S A (1992) 89:11141–510.1073/pnas.89.23.11141
    1. Johnson FK, Johnson RA. Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles. Am J Physiol Regul Integr Comp Physiol (2003) 285:R536–41
    1. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Reports (2011) 5:585–9010.1186/1752-1947-5-585
    1. Chambers DC, Tunnicliffe WS, Ayres JG. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax (1998) 53:677–910.1136/thx.53.8.677
    1. Buda K, Kulinska K, Billert H. Acute smoking effect in respect to exhaled nitric oxide – a preliminary report. Przegl Lek (2011) 68:738–41
    1. Wieslander G, Norback D, Lindgren T. Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med (2001) 58:649–5510.1136/oem.58.10.649
    1. Choi H, Schmidbauer N, Sundell J, Hasselgren M, Spengler J, Bornehag C. Common household chemicals and the allergy risks in pre-school age children. PLoS One (2010) 5:e13423.10.1371/journal.pone.0013423
    1. Robertson OH, Loosli CG, Puck TT, Wise H, Lemon HM, Lester W. Tests for the chronic toxicity of propylene glycol and triethylene glycol on monkeys and rats by vapor inhalation and oral administration. J Pharmacol Exp Ther (1947) 91:52–76
    1. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol (2012) 34:529–3710.1016/j.reprotox.2012.08.001
    1. Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol (2013) 25:354–6110.3109/08958378.2013.793439
    1. Flouris AD, Poulianiti KP, Chorti AZ, Jamurtas MS, Kouretas D, Owolabi EO, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol (2012) 50:3600–310.1016/j.fct.2012.07.025
    1. Bridges AB, Hill A, Belch JJ. Cigarette smoking increases white blood cell aggregation in whole blood. J R Soc Med (1993) 86:139–40
    1. Farsalinos KE, Romagna G. Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep (2013) 6:15–2110.4137/CCRep.S11175
    1. Noel J, Rees VW, Connolly GN. Electronic cigarettes: a new ‘tobacco’ industry? Tob Control (2011) 20:81.10.1136/tc.2010.038562

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera